ASSOCIATIONS OF METABOLIC SUBTYPES OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH RISK OF CARDIOVASCULAR MORTALITY AND ALL-CAUSE MORTALITY IN THE UNITED STATES

被引:0
|
作者
Zeng, Guyu [1 ]
Wang, Peizhi [1 ]
Yuan, Jinqing [1 ]
机构
[1] Fuwai Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1453-207
引用
收藏
页码:1968 / 1968
页数:1
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
    Kim, Donghee
    Konyn, Peter
    Sandhu, Keeryth K.
    Dennis, Brittany B.
    Cheung, Amanda C.
    Ahmed, Aijaz
    JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1284 - 1291
  • [2] Are there all-cause mortality differences between metabolic dysfunction-associated steatotic liver disease subtypes?
    Li, Mengqi
    Xie, Wen
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e53 - e54
  • [3] Nonalcoholic Fatty Liver Disease, Metabolic Dysfunction Associated Fatty Liver Disease, and Associations with All-Cause and Cause Specific Mortality
    Huang, Qi
    Zou, Xiantong
    Zhou, Xianghai
    Ji, Linong
    DIABETES, 2021, 70
  • [4] Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States
    Kim, Donghee
    Wijarnpreecha, Karn
    Cholankeril, George
    Ahmed, Aijaz
    JOURNAL OF HEPATOLOGY, 2024, 80 (02)
  • [5] Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality
    Oh, Rosa
    Kim, Seohyun
    Cho, So Hyun
    Kim, Jiyoon
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Gyuri
    Kim, Jae Hyeon
    DIABETES & METABOLISM JOURNAL, 2025, 49 (01)
  • [6] Letter: metabolic dysfunction-associated fatty liver disease increases risk of all-cause mortality in patients with chronic hepatitis C
    Zhao, Qianwen
    Deng, Yunlei
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (02) : 272 - 273
  • [7] Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease
    Min, Yu
    Wei, Xiaoyuan
    Wei, Zhigong
    Song, Ge
    Zhao, Xin
    Lei, Yi
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [8] Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort
    Cheng, Wei-Chun
    Chen, Hua-Fen
    Cheng, Hsiu-Chi
    Li, Chung-Yi
    EPIDEMIOLOGY AND HEALTH, 2024, 46 : e2024024
  • [9] Associations between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease
    Wang, Xinyu
    Wang, Aruna
    Zhang, Ruosu
    Cheng, Si
    Pang, Yuanjie
    NUTRIENTS, 2022, 14 (20)
  • [10] Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
    Kim, Donghee
    Danpanichkul, Pojsakorn
    Wijarnpreecha, Karn
    Cholankeril, George
    Ahmed, Aijaz
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)